{"disease":{"id":"opiate","name":"opiate"},"drugs":{"marketed":[{"drug_id":"nalmefene","indication_name":"Opiate-Induced Respiratory Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revex","generic_name":"NALMEFENE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":55,"revenue":"400","mechanism":""},{"drug_id":"nalmefene","indication_name":"Poisoning by opiate analgesic drug","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revex","generic_name":"NALMEFENE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":55,"revenue":"400","mechanism":""},{"drug_id":"naloxone","indication_name":"Opiate-Induced Respiratory Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"naloxone","indication_name":"Overdose of opiate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"naloxone","indication_name":"Poisoning by opiate analgesic drug","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02668549","title":"Cross-Sectional Study to Define and Validate \"Doctor/Pharmacy Shopping\" as Outcomes Suggestive of Abuse and/or Addiction","phase":"","overall_status":"COMPLETED","enrollment_count":164923,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT02751762","title":"A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain","phase":"","overall_status":"COMPLETED","enrollment_count":3600,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT02667197","title":"Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B","phase":"","overall_status":"COMPLETED","enrollment_count":2701,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT03748862","title":"The Effect of Primary Care Opioid Taper Plans on Sustained Opioid Taper","phase":"","overall_status":"COMPLETED","enrollment_count":2500,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT02667262","title":"An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data","phase":"","overall_status":"COMPLETED","enrollment_count":1667,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT05361603","title":"Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"University Hospital, Limoges","has_results":false},{"nct_id":"NCT04057820","title":"Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach","phase":"NA","overall_status":"COMPLETED","enrollment_count":1305,"lead_sponsor_name":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program","has_results":true},{"nct_id":"NCT02667158","title":"A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion","phase":"","overall_status":"COMPLETED","enrollment_count":1085,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT05665179","title":"Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis","phase":"NA","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT02678507","title":"A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT05657106","title":"Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":752,"lead_sponsor_name":"April M Young","has_results":false},{"nct_id":"NCT06810076","title":"Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":674,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT05493475","title":"Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants","phase":"NA","overall_status":"COMPLETED","enrollment_count":653,"lead_sponsor_name":"Nationwide Children's Hospital","has_results":false},{"nct_id":"NCT05980260","title":"Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":626,"lead_sponsor_name":"HELP for NOWS Consortium","has_results":false},{"nct_id":"NCT02660619","title":"Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication","phase":"","overall_status":"COMPLETED","enrollment_count":606,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT02667210","title":"Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review","phase":"","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT05116852","title":"Community and Familial Impacts of the Opioid Crisis","phase":"","overall_status":"COMPLETED","enrollment_count":578,"lead_sponsor_name":"Cambridge Health Alliance","has_results":false},{"nct_id":"NCT02669901","title":"Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":395,"lead_sponsor_name":"University of New Mexico","has_results":true},{"nct_id":"NCT05164549","title":"Extended-release Pharmacotherapy for Opioid Use Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":342,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT05336188","title":"Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":255,"lead_sponsor_name":"University of Arkansas","has_results":false},{"nct_id":"NCT02867124","title":"Long-acting Naltrexone for Pre-release Prisoners","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Friends Research Institute, Inc.","has_results":false},{"nct_id":"NCT00292136","title":"Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study","phase":"","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT06266039","title":"Introduction of Long Acting Buprenorphine in France","phase":"","overall_status":"UNKNOWN","enrollment_count":223,"lead_sponsor_name":"University of Bordeaux","has_results":false},{"nct_id":"NCT04162184","title":"Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Denver Health and Hospital Authority","has_results":false},{"nct_id":"NCT00604188","title":"A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05431985","title":"Cross-cultural Validation of a Screening Scale for the Misuse of Opioid Analgesics in Primary Care","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT03583138","title":"HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT04112186","title":"Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":157,"lead_sponsor_name":"Icahn School of Medicine at Mount Sinai","has_results":false},{"nct_id":"NCT03798470","title":"FAVOR Opioid Recovery Coaching Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Prisma Health-Upstate","has_results":false},{"nct_id":"NCT05995535","title":"Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT02617628","title":"Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT00292110","title":"Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"National Institute on Drug Abuse (NIDA)","has_results":false},{"nct_id":"NCT03971097","title":"The Effect of Self-Forgiveness on Self-Stigma in Addiction.","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT05995873","title":"A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"MindLight, LLC","has_results":false},{"nct_id":"NCT03635346","title":"Medicinal Dependence and Chronic Pain: Addictive Evaluation in CETD","phase":"","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT05029401","title":"A Study of Oral Ibogaine in Opioid Withdrawal","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"atai Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03718065","title":"Impact of Lofexidine on Stress, Craving and Opioid Use","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Medical University of South Carolina","has_results":true},{"nct_id":"NCT03985163","title":"Patient Reported Outcomes for Opioid Use Disorder","phase":"","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT03150173","title":"Onsite Buprenorphine Treatment at Syringe Exchange Programs","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Montefiore Medical Center","has_results":true},{"nct_id":"NCT03373825","title":"Rapid Self-Testing to Prevent Fentanyl Overdose Among Young People Who Use Drugs","phase":"NA","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Brown University","has_results":false},{"nct_id":"NCT05358132","title":"ARM-ED: Advanced Respiratory Monitoring Events in Drug Toxicity","phase":"","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"NHS Greater Glasgow and Clyde","has_results":false},{"nct_id":"NCT03911739","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT02660606","title":"A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire","phase":"","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT05569031","title":"Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT03036917","title":"Cognitive Function Before and After Opioid Reduction in Patients With Chronic Pain","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Zealand University Hospital","has_results":false},{"nct_id":"NCT03397212","title":"Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT01550341","title":"HIV, Buprenorphine, and the Criminal Justice System","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Yale University","has_results":true},{"nct_id":"NCT05256485","title":"Comparison Between Different Psychotherapy Interventions Regarding Their Effect on Substance Craving","phase":"NA","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Sara Harby","has_results":false},{"nct_id":"NCT02741076","title":"Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":44,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":true},{"nct_id":"NCT03527485","title":"Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Yale University","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}